Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,837,566
in 4 filings, $626K under 10b5-1 plans

Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 78 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-10 Cancelmo Peter B Grant or award · Stock Option(Right to Buy) +20,000 20,000
2019-06-07 Shah Rajiv Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2019-06-07 Hood Leroy E. MD PhD Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2019-06-07 HANISH ARNOLD C Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2019-06-07 Demopulos Peter A MD Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2019-06-07 Cable Thomas J. Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2019-06-07 Aspiri Ray Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2019-06-07 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +10,000 $6.05 $61K 210,645
2019-06-07 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Righ to Buy) −10,000 43,996
2019-02-09 Bumol Thomas F. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-02-08 Kelbon Marcia S. VP Patent and General Counsel Grant or award · Stock Option (right to buy) +65,000 65,000
2019-02-08 JACOBSEN MICHAEL A VP Finance and CAO Grant or award · Stock Option (right to buy) +65,000 65,000
2019-02-08 Demopulos Gregory A MD Chairman, CEO & President Grant or award · Stock Option (right to buy) +425,000 425,000
2018-08-31 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +7,529 $4.10 $31K 200,174
2018-08-31 Kelbon Marcia S. VP Patent and General Counsel Sale −2,192 $25.31 $55K 197,982
2018-08-31 Kelbon Marcia S. VP Patent and General Counsel Sale −5,337 $25.93 $138K 192,645
2018-08-31 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +8,000 $6.05 $48K 200,645
2018-08-31 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −7,529 0
2018-08-31 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −8,000 53,996
2018-08-30 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +35,000 $4.10 $144K 227,645

Page 11 of 20 · 391 trades